Tag: Ruxolitinib
Best Creams for Dry Skin: What Ruxolitinib Research Shows EMJ Source link
CHMP Issues Positive Opinion for Ruxolitinib Cream for Adults With Moderate AD The Dermatology Digest Source link
Janus kinase (JAK) inhibitors have been established a leading drug class in a number of chronic skin diseases. Recent data lends to one researcher’s perspective that one JAK inhibitor’s efficacy in eczema sets it in its own class—and another JAK inhibitor’s safety risks are not actually applicable to the rest available in dermatologic care. In […]
Ruxolitinib cream 1.5% (Opezlura) was approved by the US Food and Drug Administration (FDA) this July for the treatment of nonsegmental vitiligo—a novel, breakthrough indication for a topical JAK inhibitor in a space with few options. Incyte’s agent may be next considered for a chronic skin disease with a more robust armamentarium: atopic dermatitis, which […]